°øÁö»çÇ×

2019³â ´ëÇѾÏÇÐȸ Çмú»ó ¼ö»óÀÚ
ÀÛ¼ºÀÚ
ÇÐȸ°ü¸®ÀÚ
ÀÛ¼ºÀÏ
2019-07-08
Á¶È¸
3055
2019³â ´ëÇѾÏÇÐȸ Çмú»ó ¼ö»óÀÚ ¸í´Ü
1. Á¦ 11ȸ ´ëÇѾÏÇÐȸ ±âÃÊ¿ì¼ö³í¹®»ó (CRT¿¡ °ÔÀçµÈ ±âÃÊ³í¹®, »ó±Ý °¢ 250¸¸¿ø)
No. ¼ö»óÀÚ Á¦ ¸ñ ÆäÀÌÁö¹øÈ£
1 À̺´¶õ (¼­¿ïÀÇ´ë ÇغÎÇб³½Ç) FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation (1)239-254
2 ¾ç¹ÌÈñ (¼÷¸í¿©´ë ¾àÇдëÇÐ) Proteomic Biomarkers for Bisphenol A–Early Exposure and Women’s Thyroid Cancer (1)111-117
2. Á¦ 9ȸ ¸ÓÅ© ¾ÏÇмú»ó (CRT¿¡ °ÔÀçµÈ ÀÓ»ó³í¹® Áß ´ëÀå¾Ï ¶Ç´Â µÎ°æºÎ ³í¹®, »ó±Ý °¢ 200¸¸¿ø)
No. ¼ö»óÀÚ Á¦ ¸ñ ÆäÀÌÁö¹øÈ£
1 Ãֱͼ± (±¹¸³¾Ï¼¾ÅÍ ¾Ï°ËÁø»ç¾÷°ú) Stages of Adoption for Fecal Occult Blood Test and Colonoscopy Tests for Colorectal Cancer Screening in Korea (2)416-427
2 ÀÌÀÎ±Ô (°¡Å縯ÀÇ´ë¿Ü°ú) Effect of Adjuvant Chemotherapy on Stage II Colon Cancer: Analysis of Korean National Data (4)1149-1163
3 ÀåÈ«¼® (°¡Å縯ÀÇ´ë ¹æ»ç¼±Á¾¾çÇаú) The Impact of Surgical Timing on Pathologic Tumor Response after Short Course and Long Course Preoperative Chemoradiation for Locally Advanced Rectal Adenocarcinoma (3)1039-1050
3. Á¦ 11ȸ ·Î½´ ¾ÏÇмú»ó (CRT¿¡ °ÔÀçµÈ ÀÓ»ó & Translational ³í¹® 10Æí, »ó±Ý °¢ 200¸¸¿ø)
No. ¼ö»óÀÚ Á¦ ¸ñ ÆäÀÌÁö¹øÈ£
1 ¹æ¿µÁÖ (¼­¿ïÀÇ´ë ³»°ú) Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors (3)835-842
2 ¾ç½ÂÈ£ (°¡Å縯ÀÇ´ë ½Å°æ¿Ü°ú) High-Dose Metformin Plus Temozolomide Shows Increased Anti-tumor Effects in Glioblastoma In Vitro and In Vivo Compared with Monotherapy (4)1331-1342
3 Àӹΰæ (±¹¸³¾Ï¼¾ÅÍ ¾Ï¿¹¹æ»ç¾÷°ú) Awareness of and Attitudes toward Human Papillomavirus Vaccination among Adults in Korea: 9-Year Changes in Nationwide Surveys (2)436-444
4 ¹Ú¼ö°æ (¼­¿ïÀÇ´ë ¿¹¹æÀÇÇб³½Ç) Effectiveness of Gastric Cancer Screening on Gastric Cancer Incidence and Mortality in a Community-Based Prospective Cohort (2)582-589
5 ¼­µ¿Ã¶ (Áß¾Ó´ëÇб³ ¾àÇдëÇÐ)/ ±è¿­È« (°í·ÁÀÇ´ë ³»°ú) Gemcitabine and Docetaxel Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective Study (1)175-182
6 ±è½Å¹Ì (â¿ø´ëÇб³ °£È£´ëÇÐ) Experiences and Opinions Related to End-of-Life Discussion: From Oncologists' and Resident Physicians' Perspectives (2)614-623
7 ¸í½Â±Ç (±¹¸³¾Ï¼¾ÅÍ ¾Ï¿¹¹æ°ËÁø¼¾ÅÍ) Light Alcohol Drinking and Risk of Cancer: A Meta-Analysis of Cohort Studies (2)474-487
8 ³²ÀºÁö (¿¬¼¼ÀÇ´ë »êºÎÀΰú) Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2 (3)917-925
9 ÀÓÈ£¿µ (»ï¼º¼­¿ïº´¿ø ³»°ú) Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study (2)488-494
10 ±èÁø±¹ (»ï¼º¼­¿ïº´¿ø ÈäºÎ¿Ü°ú) Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with EGFR-Mutant Non-small Cell Lung Cancer (1)95-102
4. Á¦ 8ȸ ±¤µ¿¾ÏÇмú»ó
  SCI Àú³Î¿¡ ¹ßÇ¥ µÈ ³í¹® Áß CRTÀú³ÎÀÇ IF Çâ»ó¿¡ ±â¿©ÇÑ ³í¹®ÀÇ Ã¥ÀÓ ÀúÀÚ (±âÃÊ, Áß°³ ¹× ÀÓ»ó, ´Ù¼ö ¹ßÇ¥)
No. ÀúÀÚ ¹× ¼Ò¼Ó ³í¹®Á¦¸ñ °ÔÀçÇмúÁö
1 ±èöȣ (¾ÆÁÖÀÇ´ë À̺ñÀÎÈÄ°ú) HSPA5 negatively regulates lysosomal activity through ubiquitination of MUL1 in head and neck cancer Autophagy. 2018;14(3):385-403
2 ÃÖÀÏÁÖ (±¹¸³¾Ï¼¾ÅÍ ³»°ú) Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer N Engl J Med. 2018;378(12):1085-95
3 ÀüÀç°ü (±¹¸³¾Ï¼¾ÅÍ ¾Ï°ËÁø»ç¾÷°ú) Risk of Interval Cancer in Fecal Immunochemical Test Screening Significantly Higher During the Summer Months: Results from the National Cancer Screening Program in Korea Am J Gastroenterol. 2018;113(4):611621.
5. Á¦11ȸ ´ëÇѾÏÇÐȸÁö Best Reviewer»ó (4¸í ¼±Á¤, »ó±Ý °¢ 50¸¸¿ø)
  : 2018³â 1¿ù ~12¿ù±îÁö ½É»çÇÑ À§¿øÀ¸·Î ½É»ç±â°£À» ÁؼöÇÏ°í, ½É»çÀÇ °´°ü¼º, Ÿ´ç¼º, °Ç¼³ÀûÀÎ ÀÇ°ßÀ¸·Î ³í¹®ÀÇ ÁúÀû Çâ»ó¿¡ ±â¿©ÇÑ ½É»çÀ§¿ø ¼±Á¤
No. ¼ö»óÀÚ
1 ±è¿ì¿µ (¼÷¸í¿©ÀÚ´ëÇб³ ¾àÇдëÇÐ)
2 ±èÁ¾±¤ (°æºÏÀÇ´ë ³»°ú)
3 ±èŹΠ(¼­¿ïÀÇ´ë ³»°ú)
4 ÇÑÁö¿¬ (±¹¸³¾Ï¼¾ÅÍ ³»°ú)